Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
114.64
+0.70 (0.61%)
Dec 20, 2024, 4:00 PM EST - Market closed

Ligand Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
45.2452.15-33.3657.14-2.99629.3
Upgrade
Depreciation & Amortization
34.6535.6451.3750.9527.9743.73
Upgrade
Other Amortization
2.451.986.2621.5324.6929.99
Upgrade
Loss (Gain) From Sale of Assets
--2.12---17.11-812.8
Upgrade
Asset Writedown & Restructuring Costs
26.490.92----
Upgrade
Loss (Gain) From Sale of Investments
-90.27-47.68-28.524.1118.41-11.32
Upgrade
Loss (Gain) on Equity Investments
13.411.83----
Upgrade
Stock-Based Compensation
39.2925.7460.2938.7830.7324.52
Upgrade
Other Operating Activities
13.6115.5216.15-36.71-15.4371.3
Upgrade
Change in Accounts Receivable
2.04-2.655.32-28.62-26.0625.46
Upgrade
Change in Inventory
7.76-10.8712.06-0.43-17.8-2.06
Upgrade
Change in Accounts Payable
5.37-4.7-3.342.81-1.25-6.66
Upgrade
Change in Unearned Revenue
-0.980.42-6.28-17.8729.24-1.15
Upgrade
Change in Income Taxes
-8.21-1.781.58-3.989.14-11.22
Upgrade
Change in Other Net Operating Assets
-14.23-14.876.34-8.93-4.95-8.43
Upgrade
Operating Cash Flow
76.6449.58137.8578.854.59-29.34
Upgrade
Operating Cash Flow Growth
-19.31%-64.04%74.94%44.36%--
Upgrade
Capital Expenditures
-1.53-3.52-17.92-8.76-4.46-2.55
Upgrade
Cash Acquisitions
--10.41---404.88-11.84
Upgrade
Divestitures
----22.06-
Upgrade
Sale (Purchase) of Intangibles
-49.91-49.910.090.491.36812.8
Upgrade
Investment in Securities
-48.1152.15182.4240.01615.67-326.82
Upgrade
Other Investing Activities
-15.78--0.96-1.221.9-4.67
Upgrade
Investing Cash Flow
-115.33-11.68163.6230.52231.65466.92
Upgrade
Long-Term Debt Repaid
--76.9-261-164.95-231.76-27.32
Upgrade
Net Debt Issued (Repaid)
-0.02-76.9-261-164.95-231.76-27.32
Upgrade
Issuance of Common Stock
52.7822.453.2333.763.023
Upgrade
Repurchase of Common Stock
-3.46-4.55-8.24-6.02-79.48-457.47
Upgrade
Other Financing Activities
32.77-0.95-9.98-0.56-2.33-3.38
Upgrade
Financing Cash Flow
82.07-59.95-275.99-137.76-310.55-485.17
Upgrade
Foreign Exchange Rate Adjustments
0.38----0.08
Upgrade
Net Cash Flow
43.76-22.0525.48-28.44-24.31-47.51
Upgrade
Free Cash Flow
75.1246.06119.9370.0450.13-31.89
Upgrade
Free Cash Flow Growth
-16.31%-61.60%71.23%39.72%--
Upgrade
Free Cash Flow Margin
49.28%35.07%61.11%29.00%30.65%-26.51%
Upgrade
Free Cash Flow Per Share
4.092.597.114.062.98-1.61
Upgrade
Cash Interest Paid
0.260.291.433.034.465.83
Upgrade
Cash Income Tax Paid
26.118.7711.643.722.13103.82
Upgrade
Levered Free Cash Flow
16.96-4.76144.5137.03123.51885.43
Upgrade
Unlevered Free Cash Flow
17.99-4.59144.932.6117.57877.78
Upgrade
Change in Net Working Capital
17.820.42-53.0685.65-40.29-2.86
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.